| Filed | Description | |
|---|---|---|
| 8/1/24 | 1.01 Material Agreement | → |
| 12/7/23 | 1.01 Material Agreement | → |
| 10/12/23 | 1.01 Material Agreement | → |
| 8/16/22 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 8/12/22 | 1.01 Material Agreement | → |
| 4/13/21 | 1.01 Material Agreement | → |
| ↓ 4 more | ||
Cerevel Therapeutics Holdings, Inc. was an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.